Contact Information

Center for Neurovisceral Sciences and Women's Health
Box 951792, VA Greater LA Healthcare System Bldg 115, Rm 128
Los Angeles, CA 90095-1792
On-campus mail: 179247
Tel: (310) 478-3711 x40580
Fax:(310) 794-2864
E-mail: brandall@ucla.edu

Biosketch

Dr. Suyenobu conducts the processing and analysis of the neuroimaging data for the UCLA Center for Neurovisceral Sciences and Women's Health. Among the current projects are those investigating levels of functional brain activity associated with the effects of pharmacological interventions for gastrointestinal disorders, the placebo effect, sex differences in response to visceral discomfort, and acupuncture. His previous research includes assessment of topographic EEG and cognitive neuropsychological correlates of acute alcohol intoxication in normal subjects, EEG correlates of aircraft pilot performance, and altered states of consciousness.

Selected References

Mayer EA, Berman S, Derbyshire SWG, Suyenobu B, Chang L, Fitzgerald L, Mandelkern M, Hamm L, Vogt B, Naliboff BD. The effect of the 5-HT3 receptor antagonist, Alosetron, on brain responses to visceral stimulation in irritable bowel syndrome patients. Alimentary Pharmacology and Therapeutics 2002;16:1357-1366.

Berman SM, Suyenobu B, Gordon W, Mandelkern M, Naliboff B, Mayer EA. Evidence for antinociceptive deactivation of the amygdala in functional GI disorders. Gastroenterology 2002;122:A313.

Berman SM, Chang L, Suyenobu B, Derbyshire S, Stains J, FitzGerald L, Mandelkern M, Hamm L, Naliboff B, Mayer EA. Condition-specific deactivation of brain regions by 5-HT3 receptor antagonist Alosetron. Gastroenterology 2002;123:969-977.